More people than ever are living with dementia—but in Europe and the US, the risk of developing the condition is actually down, a striking new paper found.  

A flurry of research is identifying patterns that set apart COVID-19 patients who are prone to deadly immune system overreactions. During these “cytokine storms,” molecules leading the first line of immune defense fail to stand down so that antibodies and T cells can take…

While the world awaits a vaccine, drugmakers—and the US government—are throwing resources behind a potential stop-gap solution: custom antibodies designed to fight COVID-19.   Grown in bioreactor vats, these monoclonal antibodies are copies of naturally occurring proteins…

As the pandemic drags on, women are delaying voluntary health care appointments, setting the stage for serious long-term health problems.   Take breast cancer: The National Cancer Institute estimates 5,000 excess deaths from the disease over the next decade—and that’s…

The WHO has completed its initial scoping mission to China on the origins of SARS-CoV2, CIDRAP reports, setting the stage for a deeper epidemiological investigation.

Contact tracing, an early hope for containing the coronavirus, is failing in some US states.

Africa is nearing 1 million COVID-19 cases after they almost doubled in the past 3 weeks to 889,457—with 18,806 deaths, WHO reports.  

It may be hard to imagine, but this year’s hajj pilgrimage—an event that normally brings 2 million+ Muslims worshippers a year to the sacred city of Mecca—began yesterday with will only about 1,000 lucky pilgrims, 

Many studies have investigated the immediate and short-term impact of Ebola—but little is known about its long-term toll on those lucky enough to survive.   A new study of survivors of the 2013–2016 Ebola outbreak in Guinea sheds some light, finding that Ebola’s toll can…

When given a choice, Aedes aegypti mosquitoes, which transmit dangerous diseases like dengue, opt to bite humans rather than other animals.